New developments and standard of care in the management of advanced gastric cancer

Léonard Depotte(Inserm), Aziz Zaanan(Université Paris Cité), Chloé Broudin(Assistance Publique – Hôpitaux de Paris), Antoine Mariani(Université Paris Cité), Vlad-Adrian Afrăsânie(Institutul Regional de Oncologie), Juliette Palle(Université Paris Cité), Cosimo Rasola(Istituto Oncologico Veneto)

Clinics and Research in Hepatology and Gastroenterology

November 10, 2023

10.1016/j.clinre.2023.102245

Cited by 15

Related Papers

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

|BMJ|2022|494

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy

|JAMA Oncology|2017|146

Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians

|Cancer Treatment Reviews|2018|71

Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies

|Liver International|2015|52

Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula

|Nanoscale|2020|44